Vale (VALE) (UTIW) (RDK) (REGN) (RMTI) (RSTI) Ratings, Price Targets

Vale (NASDAQ: VALE), UTi Worldwide Inc. (NASDAQ: UTIW), Ruddick Corporation (NYSE: RDK), Regeneron Pharma (NASDAQ: REGN), Rockwell Medical (NASDAQ: RMTI) and Rofin-Sinar Technologies (NASDAQ: RSTI) ratings and price targets.

UTi Worldwide Inc. (UTIW) was downgraded by Zacks Investment Research from a “neutral” rating to an “underperform” rating.

Vale (VALE) was downgraded by HSBC (NYSE:HBC) to a “neutral” rating.

Ruddick Corporation (RDK) was upgraded by Zacks Investment Research from an “underperform” rating to a “neutral” rating.

Regeneron Pharma (REGN) was upgraded by Robert W. Baird from a “neutral” rating to an “outperform” rating. They have a price target of $81.00 on the firm, up from $56.00.

Rockwell Medical (RMTI) was upgraded by Zacks Investment Research from an “underperform” rating to a “neutral” rating.

Rofin-Sinar Technologies (RSTI) was upgraded by Zacks Investment Research from an “underperform” rating to a “neutral” rating.